The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
May. 10, 2019
Applicant:
Biocytogen Pharmaceuticals (Beijing) Co., Ltd, Beijing, CN;
Inventors:
Yuelei Shen, Beijing, CN;
Yanan Guo, Beijing, CN;
Chaoshe Guo, Beijing, CN;
Yang Bai, Beijing, CN;
Jiawei Yao, Beijing, CN;
Lei Zhao, Beijing, CN;
Rui Huang, Beijing, CN;
Assignee:
Biocytogen Pharmaceuticals (Beijing) Co., Ltd, Beijing, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01K 67/027 (2006.01); A61K 49/00 (2006.01); C07K 14/705 (2006.01); C12N 15/11 (2006.01); C12N 15/85 (2006.01); C12N 15/89 (2006.01);
U.S. Cl.
CPC ...
A01K 67/0278 (2013.01); A61K 49/0008 (2013.01); C07K 14/70503 (2013.01); C12N 15/11 (2013.01); C12N 15/8509 (2013.01); A01K 2207/15 (2013.01); A01K 2217/072 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0331 (2013.01); C07K 2319/03 (2013.01); C12N 15/89 (2013.01); C12N 2310/20 (2017.05); C12N 2800/107 (2013.01); C12N 2810/10 (2013.01);
Abstract
The present disclosure relates to the genetically modified non-human animals that express a human or chimeric (e.g., humanized) Lymphocyte Activation Gene 3 (LAG-3), and methods of use thereof.